Moexipril HCl is the hydrochloride salt of moexipril, a prodrug angiotensin-converting enzyme (ACE) inhibitor primarily used in the treatment of hypertension. It lowers high blood pressure by inhibiting ACE, leading to vasodilation and easier blood flow, thereby reducing risks of strokes, heart attacks, and kidney problems. It is also indicated for heart failure management to improve survival and reduce hospitalizations, and post-heart attack to enhance survival and prevent further cardiac events. Offered as a high-purity reagent (≥98%) for pharmaceutical research, API development, synthesis of formulations, and analytical purposes. Consistent daily dosing at the same time is recommended for optimal efficacy in clinical use, often combined with lifestyle changes such as diet and exercise.